4 research departments
750 employees
45 nationalities
55 research teams
16 ERC laureates
260 publications per year
24000 m² lab area

Support us through

Fondation universite de Strasbourg

Mei LI publications

  • Chromatin remodellers Brg1 and Bptf are required for normal gene expression and progression of oncogenic Braf-driven mouse melanoma.

    Laurette P(1), Coassolo S(1), Davidson G(1), Michel I(1), Gambi G(1), Yao W(1), Sohier P(2)(3)(4), Li M(1), Mengus G(1), Larue L(2)(3)(4), Davidson I(5)(6).

    Cell Death Differ May 7, 2019

  • Coordinated Dialogue between UHRF1 and DNMT1 to Ensure Faithful Inheritance of Methylated DNA Patterns.

    Bronner C(1), Alhosin M(2), Hamiche A(3), Mousli M(4).

    Genes (Basel) Jan. 18, 2019

  • Deciphering the Mammary Stem Cell Niche: A Role for Laminin-Binding Integrins.

    Romagnoli M(1), Cagnet S(1), Chiche A(1), Bresson L(1), Baulande S(2), de la Grange P(3), De Arcangelis A(4), Kreft M(5), George-Labouesse E(4), Sonnenberg A(5), Deugnier MA(6), Raymond K(6), Glukhova MA(6), Faraldo MM(7).

    Stem Cell Reports April 9, 2019

  • Disrupting the IL-36 and IL-23/IL-17 loop underlies the efficacy of calcipotriol and corticosteroid therapy for psoriasis.

    German B(1)(2)(3)(4), Wei R(1)(2)(3)(4), Hener P(1)(2)(3)(4), Martins C(5), Ye T(1)(2)(3)(4), Gottwick C(6), Yang J(6), Seneschal J(5), Boniface K(5), Li M(1)(2)(3)(4).

    JCI Insight Jan. 24, 2019

  • Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.

    Galluzzi L(1)(2)(3), Vitale I(4)(5), Aaronson SA(6), Abrams JM(7), Adam D(8), Agostinis P(9), Alnemri ES(10), Altucci L(11), Amelio I(12), Andrews DW(13)(14)(15), Annicchiarico-Petruzzelli M(16), Antonov AV(12), Arama E(17), Baehrecke EH(18), Barlev NA(19), Bazan NG(20), Bernassola F(21), Bertrand MJM(22)(23), Bianchi K(24), Blagosklonny MV(25), Blomgren K(26)(27), Borner C(28)(29), Boya P(30), Brenner C(31)(32), Campanella M(4)(5)(33)(34), Candi E(16)(21), Carmona-Gutierrez D(35), Cecconi F(4)(36)(37), Chan FK(38), Chandel NS(39), Cheng EH(40), Chipuk JE(6), Cidlowski JA(41), Ciechanover A(42), Cohen GM(43), Conrad M(44), Cubillos-Ruiz JR(45)(46), Czabotar PE(47)(48), D'Angiolella V(49), Dawson TM(50)(51)(52)(53), Dawson VL(50)(51)(53)(54), De Laurenzi V(55), De Maria R(56), Debatin KM(57), DeBerardinis RJ(58), Deshmukh M(59), Di Daniele N(60), Di Virgilio F(61), Dixit VM(62), Dixon SJ(63), Duckett CS(64), Dynlacht BD(65)(66), El-Deiry WS(67)(68), Elrod JW(69), Fimia GM(70)(71), Fulda S(72)(73)(74), Garcia-Saez AJ(75), Garg AD(9), Garrido C(76)(77)(78), Gavathiotis E(79)(80)(81)(82), Golstein P(83), Gottlieb E(42)(84), Green DR(85), Greene LA(86), Gronemeyer H(87)(88)(89)(90), Gross A(91), Hajnoczky G(92), Hardwick JM(93), Harris IS(94), Hengartner MO(95), Hetz C(96)(97)(98), Ichijo H(99), Jaattela M(100), Joseph B(101), Jost PJ(102), Juin PP(103)(104)(105)(106), Kaiser WJ(107), Karin M(108)(109)(110)(111), Kaufmann T(112), Kepp O(113)(114)(115)(116)(117)(118), Kimchi A(17), Kitsis RN(80)(81)(82)(119)(120), Klionsky DJ(121)(122), Knight RA(12), Kumar S(123), Lee SW(124), Lemasters JJ(125)(126), Levine B(127)(128)(129), Linkermann A(130), Lipton SA(131)(132)(133), Lockshin RA(134)(135), Lopez-Otin C(136), Lowe SW(137)(138), Luedde T(139), Lugli E(140)(141), MacFarlane M(12), Madeo F(35)(142), Malewicz M(12), Malorni W(143), Manic G(4)(5), Marine JC(144)(145), Martin SJ(146), Martinou JC(147), Medema JP(148)(149), Mehlen P(150)(151)(152)(153)(154)(155), Meier P(156), Melino S(157), Miao EA(158)(159)(160), Molkentin JD(161), Moll UM(162), Munoz-Pinedo C(163), Nagata S(164), Nunez G(165)(166), Oberst A(167)(168), Oren M(169), Overholtzer M(170), Pagano M(66)(171)(172), Panaretakis T(173)(174), Pasparakis M(175)(176), Penninger JM(177), Pereira DM(178), Pervaiz S(179)(180)(181), Peter ME(182)(183), Piacentini M(4)(70), Pinton P(61)(184)(185), Prehn JHM(186), Puthalakath H(187), Rabinovich GA(188)(189), Rehm M(190)(191), Rizzuto R(192), Rodrigues CMP(193), Rubinsztein DC(194), Rudel T(195), Ryan KM(84), Sayan E(196), Scorrano L(197)(198), Shao F(199), Shi Y(200)(201)(202), Silke J(48)(203), Simon HU(112), Sistigu A(56)(204), Stockwell BR(205)(206), Strasser A(47), Szabadkai G(192)(207)(208), Tait SWG(84), Tang D(209)(210)(211)(212)(213)(214), Tavernarakis N(215), Thorburn A(216), Tsujimoto Y(217), Turk B(218)(219), Vanden Berghe T(22)(23), Vandenabeele P(22)(23), Vander Heiden MG(220)(221)(222), Villunger A(223), Virgin HW(224), Vousden KH(208), Vucic D(225), Wagner EF(226), Walczak H(227), Wallach D(228), Wang Y(229), Wells JA(230), Wood W(231), Yuan J(94)(232), Zakeri Z(233), Zhivotovsky B(101)(234), Zitvogel L(114)(235)(236)(237), Melino G(12)(21), Kroemer G(238)(239)(240)(241)(242)(243)(244).

    Cell Death Differ Jan. 23, 2018

  • S100A3 a partner protein regulating the stability/activity of RARalpha and PML-RARalpha in cellular models of breast/lung cancer and acute myeloid leukemia.

    Gianni M(1), Terao M(1), Kurosaki M(1), Paroni G(1), Brunelli L(2), Pastorelli R(2), Zanetti A(1), Lupi M(3), Acquavita A(1), Bolis M(1), Fratelli M(1), Rochette-Egly C(4), Garattini E(5).

    Oncogene Dec. 7, 2018

  • Targeting microRNA/UHRF1 pathways as a novel strategy for cancer therapy.

    Choudhry H(1)(2)(3)(4), Zamzami MA(1)(2)(3), Omran Z(5), Wu W(6), Mousli M(7), Bronner C(8), Alhosin M(1)(2)(3).

    Oncol Lett Jan 2018

  • Thymoquinone challenges UHRF1 to commit auto-ubiquitination: a key event for apoptosis induction in cancer cells.

    Ibrahim A(1)(2), Alhosin M(3)(4), Papin C(1), Ouararhni K(1), Omran Z(5), Zamzami MA(3)(4), Al-Malki AL(3), Choudhry H(3)(4), Mely Y(6), Hamiche A(1), Mousli M(6), Bronner C(1).

    Oncotarget June 19, 2018

Imprimer Envoyer

Université de Strasbourg
INSERM
CNRS

IGBMC - CNRS UMR 7104 - Inserm U 1258
1 rue Laurent Fries / BP 10142 / 67404 Illkirch CEDEX / France Tél +33 (0)3 88 65 32 00 / Fax +33 (0)3 88 65 32 01 / directeur.igbmc@igbmc.fr